Viatris Investing Cash Flow increased by 231.3% to $277.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 526.1%, from -$65.10M to $277.40M. Over 3 years (FY 2022 to FY 2025), Investing Cash Flow shows a downward trend with a -33.8% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$219.10M | -$66.90M | -$82.10M | -$115.00M | $1.74B | -$749.50M | -$86.80M | -$54.90M | $0.00 | -$154.30M | $375.80M | $1.75B | $0.00 | -$65.10M | -$52.50M | -$98.90M | -$211.20M | $277.40M |
| QoQ Change | — | +69.5% | -22.7% | -40.1% | >999% | -143.1% | +88.4% | +36.8% | +100.0% | — | +343.6% | +365.1% | -100.0% | — | +19.4% | -88.4% | -113.5% | +231.3% |
| YoY Change | — | — | — | — | +893.3% | <-999% | -5.7% | +52.3% | -100.0% | +79.4% | +532.9% | >999% | — | +57.8% | -114.0% | -105.7% | — | +526.1% |